-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓
Börse Xetra FrankfurtEURISIN US717081ER06-
PfizerBörse NYSE New York Stock ExchangeISIN US7170811035 WKN: 852009USDSymbol PFE
-
PFIZER INCBörse Börse HamburgISIN US717081ED10EURSymbol PFE
-
PfizerBörse Börse StuttgartISIN US717081DK61EURSymbol PFE
-
PfizerBörse Xetra FrankfurtISIN US717081ER06EURSymbol PFE
-
PFIZER INCBörse Börse DüsseldorfISIN XS1574158082EURSymbol PFE
-
PFIZER INCBörse Börse MünchenISIN US717081DZ31EURSymbol PFE
-
PFIZER INCBörse Gettex System der Börse MünchenISIN US717081ES88EURSymbol PFE
-
PFIZER INCBörse Tradegate System der Deutsche Börse AG (60%)ISIN US717081EQ23EURSymbol PFE
-
PFIZER INCBörse Quotrix System der Börse DüsseldorfISIN US717081DE02EURSymbol PFE
-
PFIZER INCBörse Börse FrankfurtISIN XS1574157357EURSymbol PFE
-
PfizerBörse Xetra FrankfurtEURISIN US717081EY56
-
PfizerBörse Börse MünchenEURISIN US717081FA61
-
PfizerBörse SSE Stockholm Stock ExchangeISIN US717081EZ22SEKSymbol PFE
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtISIN US717081EK52MXNSymbol PFE
-
PfizerBörse Bolsa de Comercio de Buenos AiresUSDISIN US717081DV27
-
PfizerBörse Bolsa Mexicana de Valore Mexiko-StadtMXNISIN US717081DH33
-
PfizerBörse BUEUSDISIN US717081EV18
-
ISIN US717081EX73EURSymbol PFE
-
PfizerBörse OMXSSEKISIN US7170811035
-
EURISIN US717081EJ89
-
PFIZER INCBörse SSEISIN US717081EP40
-
ISIN US717081ER06
Symbol PFE
Währung
EUR
Börse
Xetra Frankfurt Zeitzone: Europe/Berlin
Firmenname
Pfizer Inc
Marktkapitalisierung
197.500.079.920 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 3 Datenquellen:
204.882.624.512 oder 216.419.000.000 oder 171.198.615.249
Mitarbeiter
83.400 (+- 6%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
88.300 oder 78.500 Mitarbeiter
Anzahl Aktien
5.558.396.599
KGV
18.68 (+- 28%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
23.97 oder 13.4
EBITDA 19.320.000.512
PEGRatio 4.9741
Buchwert 11.744
Zahlte zuletzt am 06.05.2021 eine Dividende von 0,39 . Seit damals wurde keine Dividende mehr ausgeschüttet Übersicht
Letzte Communitymeinungen
- 2 User waren zuletzt bullisch
- Im Alpha-Tester Battle 2021
-
casixxx
-
Harry386
Ein User hat Pfizer abonniert.
Aktionärsstruktur der Pfizer Inc
Portrait der Pfizer Aktie
Das Unternehmen Pfizer Inc aus USA beschäftigt 83.400 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie, Pharma tätig.
Tochterunternehmen von Pfizer sind: Pfizer Ltd/India, PFIZER LTD., Pfizer Limited.
Das Unternehmen Pfizer Inc ist in mehr als 89 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter VanEck Vectors Morningstar Durable Dividend ETF gewichtet Pfizer mit 5,94% im ETF.
Es ist auch möglich über Anleihen zu investieren. Hier findest du alle Pfizer Anleihen auf einen Blick.
Entdecke die 6 ETFs in denen Pfizer Inc am höchsten gewichtet ist Insgesamt in 89 ETFs enthalten
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Pfizer?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
1.790 News & Informationen zur Pfizer Aktie
How in the World Is Moderna Valued at More Than Half of Pfizer's Market Cap?
There are four possible answers.
Global pharmaceutical contract manufacturing market size to record 7.5% CAGR through 2027
The latest business intelligence report on ‘global pharmaceutical contract manufacturing market’ offers an accurate picture of the industry’s growth…
Two shots of Pfizer, AstraZeneca jabs show efficacy against Delta variant (NYSE:PFE)
A recently published study showed that two doses of Pfizer (PFE) – BioNTech (BNTX) or AstraZeneca's (AZN) COVID-19 vaccine are nearly as effective against the Delta…
Warburg Pincus-Backed AI Drug Firm Insilico Weighs U.S. IPO
(Bloomberg) — Insilico Medicine, a company that uses artificial intelligence to drive drug discovery, is considering a U.S. initial public offering that could raise about $300 million, according to people familiar with the matter.
Stocks shrug off virus worries; ECB in focus By Reuters
Stocks shrug off virus worries; ECB in focus
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds By Reuters
Two doses of Pfizer, AstraZeneca shots effective against Delta variant, study finds
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings
Pfizer Provides Update on U.S. FDA Review of Abrocitinib and XELJANZ® Filings | Nachricht | finanzen.net
Why BioNTech Stock Jumped Today
BioNTech and Pfizer lined up a new manufacturing partner for their COVID-19 vaccine.
Pfizer (PFE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Flash Briefing: Riots cost SA R50bn; Pfizer to produce vaccines in Cpt; J&J vaccine less effective against delta
Pfizer to start production of its Covid-19 vaccine at a facility in Cape Town to deliver more than 100m doses annually to African nations.
Johnson & Johnson forecasts $2.5B of coronavirus vaccine sales
Johnson & Johnson said it will sell $2.5 billion worth of its COVID-19 vaccine this year and pushed back against concerns over its effectiveness against the delta variant.
J&J forecasts $2.5 billion in COVID-19 vaccine sales this year
Johnson & Johnson on Wednesday forecast $2.5 billion in sales of its one-shot COVID-19 vaccine this year based on the current price of $5 per dose and said that could rise to $8 a dose by the… | July 21, 2021
Rise In Prevalence Of Functional GI Tract Disorders To Support Growth Of Parenteral Nutrition Market, Says TMR
ALBANY, N.Y., July 21, 2021 /PRNewswire/ — Parenteral nutrition refers to the process wherein a person is given the required nutrition intravenously. People
Global Anti-Inflammatory Therapeutics Market to Reach $125.55 Billion by 2028: AMR
Rise in prevalence of autoimmune diseases and chronic respiratory conditions, advent of new drugs, and surge in adoption rate of anti-inflammatory drugs…
Why Novavax Stock Should Continue To Rally
Novavax stock has rallied by almost 12% over the last week (five trading days), compared to the S&P 500 which was down by almost 3% over the same period. The stock is also up by a solid 85% year-to-date. The recent outperformance comes on the back of a broader rally in Covid vaccine stocks…
J&J vaccine produced “relatively low levels of antibodies” against Delta variant, says study
“The study examined only one aspect of protection, J&J said, and didn’t consider long-lasting responses among immune cells stimulated by its vaccine.”
Johnson & Johnson posts higher profit as healthcare demand returns
Company raises guidance for rest of the year as Covid-19 vaccination campaign continues
Pfizer, BioNTech join halting effort to produce covid-19 vaccines in Africa
Drugmakers face growing pressure from U.S., Europe to address global vaccine inequity
Johnson & Johnson raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales
The J&J shot, once touted as an important tool for vaccinations in hard-to-reach areas, has already delayed deliveries in the United States and Europe.
Pfizer, BioNTech Join Halting Effort to Produce Covid-19 Vaccines in Africa
The deal—under which the Cape Town-based Biovac Institute will fill vials of the Pfizer/BioNTech vaccine and ready them for shipment—follows growing pressure from the U.S, Europe and international organizations for drugmakers to do more to tackle global inequities in accessing Covid-19 shots.
Johnson & Johnson Posts Higher Profit as Healthcare Demand Returns
Greater demand for medical devices, drugs and consumer-health products helped boost sales for the company in the latest quarter.
J&J raises forecasts, estimates $2.5 billion in COVID-19 vaccine sales
Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
J&J Gains On Revising Guidance After Medical Devices Boost In Q2 By Investing.com
J&J Gains On Revising Guidance After Medical Devices Boost In Q2
Moderna : Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year
Johnson & Johnson on Wednesday forecast just $2.5 billion in 2021 sales of its COVID-19 vaccine, which has fallen way behind rival shots from Pfizer and Moderna as the company deals with… | July 21, 2021
Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year By Reuters
Johnson & Johnson forecasts $2.5 billion in COVID-19 vaccine sales this year
Will Pfizer Be Worth More Than Tesla by 2025?
Tesla sped past Pfizer last year.
Covid Rampages Through Asia; WHO’s Vaccine Target: Virus Update
(Bloomberg) — One dose of Johnson & Johnson’s Covid-19 vaccine is much less effective against the delta and lambda variants than against the original strain of the virus, the New York Times reported, citing a study that hasn’t been peer reviewed yet.
Australia, under lockdown, sees jump in COVID-19 cases
Victoria state clocked 22 new cases, from nine the day before, its biggest increase since the outbreak began this month, even as it nears its second week of statewide lockdown.
Australia, under lockdown, sees jump in COVID-19 cases By Reuters
Australia, under lockdown, sees jump in COVID-19 cases
J&J Covid vaccine shot raises fewer antibodies against Delta variant: Study
Covid vaccine: New York University scientists found that J&J’s vaccine produced roughly five-fold lower levels of the protective antibodies against the delta variant compared to the levels raised against an early coronavirus strain.Earlier this month, J&J researchers said their own data indicated that the vaccine neutralizes the delta variant and booster shots weren’t needed
J&J single dose vaccine raises fewer antibodies against delta variant in study
New York University scientists found that J&J’s vaccine produced roughly five-fold lower levels of the protective antibodies against the delta variant compared to the levels raised against an early coronavirus strain
Worldwide Losartan Industry to 2026 – Growing Prevalence of Hypertension, Stroke and Diabetic Nephropathy Across the Globe is Driving the Market
DUBLIN, July 20, 2021 /PRNewswire/ — The 'Global Losartan Market, By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Po…
Mathes Company, Inc. Buys Coupa Software Inc, BlackRock Capital Allocation Trust, Dow Inc, Sells Iron Mountain Inc, Goldman Sachs Group Inc, JPMorgan Chase
GuruFocus Article or News written by insider and the topic is about:
Johnson & Johnson (JNJ) Option Traders Ready for Positive Earnings
A noticeable collection of put options remain in the open interest for JNJ and appear to be initiated as sell orders.
Immunity provided by COVID-19 vaccines likely to ‘wane, not plummet,’ CDC director tells Congress
Federal health officials told lawmakers it’s too soon to say whether vaccinated Americans will need a COVID-19 booster shot.
Vaccine Makers Gain After Fox News Anchors Become Jab Supporters By Investing.com
Vaccine Makers Gain After Fox News Anchors Become Jab Supporters
It’s just too soon for Covid boosters
Vaccines are working, plus the human immune system has some neat tricks up its sleeve
[Stock Discovery Method] Social Media Analysis And News Sentiment data. : StockMarket
Ive been a big fan of using social media and mainstream news stock sentiment to find upcoming stocks. It a great discovery method. I thought i would …
Global Castrate Resistant Prostate Cancer (CRPC) Market to Surpass US$ 16.4 Billion by 2028, Says Coherent Market Insights (CMI)
SEATTLE, July 20, 2021 (GLOBE NEWSWIRE) — According to Coherent Market Insights, the global castrate-resistant prostate cancer market is estimated to be…
Pfizer pulls anti-smoking drug citing potential cancer-causing agent (NYSE:PFE)
Pfizer (PFE) is voluntarily recalling the anti-smoking medication Chantix also known as varenicline, due to the presence of a nitrosamine called N-nitroso-varenicline above the…